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Ischemic and traumatic brain injuries are among the most common and important causes of disability and death worldwide. Inadequate supply of oxygen and glucose can 
trigger a characteristic pathophysiological cascade leading to 
neuronal death. After the interruption of constant supply of oxygen 
and glucose, the electron transport chain within the mitochondria 
and thereby oxidative phosphorylation is inhibited. Within 
1–2 min, this is followed by decreased levels of high-energy 
phosphates; within 4 min, it leads to the depletion of glucose 
and glycogen stores; and after 5–7 min, the cellular adenosine 
triphosphate concentration rapidly drops to near zero [1].
Permanent structural damage occurs within 5–15 min of 
oxygen deprivation, while hypoglycemia can be tolerated for up 
to 60 min. Therefore, accurate decision and timely intervention 
in a patient with cerebral insult can decrease morbidity and 
mortality [1]. We report the case of a 24-year-old American 
Society of Anaesthesiologist (ASA) physical status 1 patient, 
who suffered intracerebral hemorrhage during embolization of 
cerebral arteriovenous malformation (AVM).
CASE REPORT
A 24-year-old female ASA physical status 1 was posted for the 
left sylvian AVM embolization. The patient had the complaint of 
a headache which was moderate in intensity, on and off with no 
specific aggravating and relieving factors for the past 3 months. 
The patient underwent cerebral angiography under local anesthesia 
which showed left sylvian AVM (Fig. 1). AVM embolization 
was advised as a treatment, and the patient was posted for 
AVM embolization as an elective procedure under general 
anesthesia. After confirming nil by mouth status and obtaining 
written informed consent from the patient, she was shifted to the 
neurointervention room. Routine monitoring was done which 
included non-invasive blood pressure, electrocardiography, and 
pulse oximetry. The patient received injection glycopyrrolate 
0.2 mg, injection midazolam 2 mg, and injection fentanyl 100 µg 
as premedication. General anesthesia induction was done with 
propofol (2.5 mg/Kg) and muscle relaxation with atracurium 
(1 mg/Kg) for tracheal intubation. Tracheal intubation was done 
with 7.0-mm internal diameter Portex cuffed endotracheal tube. 
The bladder catheterization was performed for urine output 
monitoring.
The patient received intravenous heparin 2000 IU before 
starting the procedure. Neurointerventionist used Histoacryl glue 
for the embolization of AVM. During the procedure, extravasation 
of dye was noticed which suggested hemorrhage within AVM. 
To confirm the diagnosis, immediate head computed tomography 
(Dyna CT) in the catheterization laboratory was performed 
which showed temporal hematoma with midline shift (Fig. 2). 
On clinical examination, the patient’s left-sided pupil was 4 mm 
dilated, fixed, and non-reactive to light, which was suggestive of 
increased intracranial pressure (ICP) from expanding hematoma 
and imminent uncal herniation of the brain.
As the patient was anticoagulated with heparin during the 
procedure, immediately protamine 20 mg was administered to 
reverse the anticoagulant action of heparin. Injection mannitol 
20% (1.5 g/Kg) was administered. Borderline hypocapnia (ETCO2 
in range of 26–30 mm of mercury) was maintained to decrease 
the ICP. The left radial artery cannulation was done for beat-to-
beat blood pressure monitoring. As the patient was intubated and 
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paralyzed, we were unable to document the Glasgow Coma Scale. 
After repeat head CT, considering the expanding intracerebral 
hematoma, urgent neurosurgical consultation was sought and 
emergency decompression in operation theater (OT) was planned. 
The patient’s relatives were explained about the intraprocedural 
complication and further necessary management. The consent for 
the procedure was obtained from the relatives. The patient was 
shifted to OT immediately and received 1.2 g loading dose of 
injection fosphenytoin.
The left frontotemporoparietal craniotomy was performed. 
The hematoma was evacuated, and the closure was done without 
replacing the bone flap. The patient was electively ventilated 
and paralyzed in the neurointensive care unit for 2 days. On the 
2nd post-operative day, in a neurointensive care unit, the patient’s 
pupils were 2 mm and were reacting to light. The patient received 
injection fosphenytoin 150 mg as an antiepileptic 3 times a day. 
On the 3rd day, sedation and neuromuscular paralytic drugs were 
stopped. The patient was completely awake with no neurological 
deficit and successfully extubated on the 4th post-operative day. 
She underwent cranioplasty on the 13th post-operative day and 
discharged home on the 17th post-operative day without any 
neurological sequelae.
DISCUSSION
The estimates of cerebral AVM prevalence that is published 
in the medical literature are unfolded. Due to the rarity of the 
disease and the existence of asymptomatic patients, establishing 
a true prevalence rate is not feasible. However, it can be inferred 
from the incidence data to be lower than 10.3 per 100,000 
population [2]. The risk of spontaneous ICH without treatment is 
estimated to be approximately 2–4% per year for all the patients 
with untreated AVM, and approximately 2–4% of patients present 
with intracranial bleeding. Most of the patients are commonly 
present with intracranial hemorrhage than headache. According 
to the World Federation of Neurointerventional and Therapeutic, 
self-reported treatment-related complications are in the range of 
9–12% [3].
To meet the brain’s metabolic demand, an adequate cerebral 
blood flow (CBF) is required. The brain is enclosed by the non-
expandable skull, and an increase in ICP may reduce cerebral 
perfusion pressure (CPP) and impair CBF leading to cerebral 
ischemia. Both CPP and ICP are established treatment targets in 
neurocritical care [4].
“Monro-kellie doctrine” states that the brain is enclosed in 
a non-expandable case of the bone and the brain parenchyma 
is nearly incompressible. In other words, the volume of the 
intracranial compartment must remain constant, if ICP is to 
remain constant [4]. The CPP is defined as the difference 
between cerebral arterial pressure and pressure in the cerebral 
venous bed. Too low CPP causes ischemia, while too high CPP 
causes hyperemia. Decreasing CPP is particularly dangerous 
as it decreases the driving force for cerebral blood to flow and 
compromises autoregulation. CPP-oriented therapy has been 
introduced to decrease the risk of ischemia in post-injury care. 
Placement of radial arterial catheter for beat-to-beat blood 
pressure monitoring can be helpful to maintain mean arterial 
pressure at an adequate level to enhance CPP [5].
Basic medical management for increased ICP includes 
head elevation to 30°, strict avoidance of free water, seizure 
prophylaxis, and fever control. The second line of therapy 
in ventilated patients with high ICP is sedation to produce a 
quiet, motionless state. After sedation and CPP optimization, 
osmotherapy and hyperventilation usually go hand in hand to 
attain the control of elevated ICP. Mannitol and hypertonic saline 
have the greatest impact on ICP when they are administered in 
bolus doses [6].
Hyperosmolar therapy, using infusions of mannitol or 
hypertonic saline, is frequently administered to reduce ICP [7]. 
Currently, mannitol (20%) is considered as the gold standard 
hyperosmolar agent and is by far the most well studied. However, 
hypertonic saline which comes in a variety of concentrations 
is increasingly used in these settings [8]. Decompressive 
craniectomy (DC) first described by Annandale in 1894 
performed as a palliative procedure for an inoperable brain tumor. 
Figure 1: Cerebral angiography showing arteriovenous malformation
Figure 2: Dyna computed tomography showing intracerebral 
bleeding
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Kocher (1901) first proposed DC as treatment of raised ICP. 
Nowadays, DC is the treatment modality of raised refractory ICP 
and most controversial of all. DC is the most studied intervention 
for intracranial hemorrhage. The term “refractory intracranial 
hypertension” implies that ICP increased over a few hours to very 
high value and leads to the death of the patient unless aggressive 
ICP treatment is initiated. However, DC’s greatest benefit may 
require that the decision about surgery is undertaken well before 
an uncontrollable elevation in ICP occurs [9].
CONCLUSION
In this case, advanced technology like the presence of Dyna CT 
facility in the catheterization laboratory for brain imaging saved 
our time and gave us the correct diagnosis. Accurate decision and 
timely intervention of neuroprotective strategies resulted in the 
preservation of patient’s neurological function and life.
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